How to buy Turning Point Therapeutics stock
Learn how to easily invest in Turning Point Therapeutics stock.
Turning Point Therapeutics is a biotechnology business based in the US. Turning Point Therapeutics shares (TPTX) are listed on the NASDAQ and all prices are listed in US Dollars. Turning Point Therapeutics employs 267 staff and has a trailing 12-month revenue of around $1 million.
How to buy Turning Point Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – TPTX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Turning Point Therapeutics stock price (NASDAQ: TPTX)Use our graph to track the performance of TPTX stocks over time.
Turning Point Therapeutics shares at a glance
|Latest market close||$76.01|
|52-week range||$0.00 - $0.00|
|50-day moving average||$75.36|
|200-day moving average||$48.05|
|Wall St. target price||$71.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-5.57|
Buy Turning Point Therapeutics stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Turning Point Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Turning Point Therapeutics price performance over time
|1 week (2023-09-12)||N/A|
|1 month (2023-08-19)||N/A|
|3 months (2023-06-19)||N/A|
|6 months (2023-03-19)||N/A|
|1 year (2022-09-19)||N/A|
|2 years (2021-09-23)||-2.55%|
|3 years (2020-09-23)||83.57|
|5 years (2018-09-19)||N/A|
Turning Point Therapeutics financials
|Revenue TTM||$1 million|
|Gross profit TTM||$30.8 million|
|Return on assets TTM||-22.13%|
|Return on equity TTM||-36.8%|
|Market Capitalization||$3.8 billion|
TTM: trailing 12 months
Turning Point Therapeutics share dividends
We're not expecting Turning Point Therapeutics to pay a dividend over the next 12 months.
Turning Point Therapeutics share price volatility
Over the last 12 months, Turning Point Therapeutics's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Turning Point Therapeutics's is -0.1941. This would suggest that Turning Point Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Turning Point Therapeutics has bucked the trend.
Turning Point Therapeutics overview
Turning Point Therapeutics, Inc. , a clinical-stage precision oncology biopharmaceutical company, engages in designing and developing therapies that target genetic drivers of cancer. It develops a pipeline of tyrosine kinase inhibitors (TKIs) that targets genetic drivers of cancer in TKI-naïve and TKI-pretreated patients. The company's lead drug candidate repotrectinib is being evaluated in an ongoing Phase 1/2 trial called TRIDENT-1 for the treatment of patients with ROS1+ advanced non-small-cell lung cancer (NSCLC) and patients with ROS1+ and NTRK+ advanced solid tumors. It also develops TPX-0022, a MET/SRC/CSF1R inhibitor, which is in Phase 1 SHIELD-1 clinical trial for patients with advanced solid tumors harboring genetic alterations in MET; TPX-0046, a RET inhibitor that is in 1/2 SWORD-1 clinical trial for patients with advanced solid tumors harboring RET genetic alterations; and TPX-0131, an ALK inhibitor, which is in Phase 1/2 FORGE-1 study for patient with advanced or metastatic TKI-pretreated ALK-positive NSCLC. Turning Point Therapeutics, Inc. was founded in 2013 and is headquartered in San Diego, California.
Frequently asked questionsWhat percentage of Turning Point Therapeutics is owned by insiders or institutions?
Currently 0.701% of Turning Point Therapeutics shares are held by insiders and 92.519% by institutions. How many people work for Turning Point Therapeutics?
Latest data suggests 267 work at Turning Point Therapeutics. When does the fiscal year end for Turning Point Therapeutics?
Turning Point Therapeutics's fiscal year ends in December. Where is Turning Point Therapeutics based?
Turning Point Therapeutics's address is: 10628 Science Center Drive, San Diego, CA, United States, 92121 What is Turning Point Therapeutics's ISIN number?
Turning Point Therapeutics's international securities identification number is: US90041T1088 What is Turning Point Therapeutics's CUSIP number?
Turning Point Therapeutics's Committee on Uniform Securities Identification Procedures number is: 90041T108
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert